Carlson Capital Management »

Immunitybio shares owned by Carlson Capital Management

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Carlson Capital Management from 13F filings

Historical chart of Carlson Capital Management investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Carlson Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Carlson Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $96k 18k 5.37
2023-12-31 $88k 18k 5.02

More positions owned by Carlson Capital Management

Ea Series Trust Ccm Global Equit
Etf Ser Solutions Distillate Us (DSTL)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Dimensional Etf Trust Intl High Profit (DIHP)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Pacer Fds Tr Developed Mrkt (ICOW)
Vanguard Index Fds Total Stk Mkt (VTI)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Vanguard Index Fds Real Estate Etf (VNQ)
UnitedHealth (UNH)

View all positions for Carlson Capital Management

Top funds holding Immunitybio

Vanguard Group
Credit Suisse
Jpmorgan Chase & Co
Goldman Sachs Group
Charles Schwab Investment Management
Bank of America Corporation
Jane Street
D. E. Shaw & Co
Barclays
Citadel Advisors
Bank of New York Mellon
Bsc Private Wealth Management
Citigroup
Bank Of Montreal
Alliancebernstein

View all funds holding Immunitybio